Leah Rose Turner

Leah Turner practices at Good Shepherd Penn Partners - HOPD (3400 Spruce Street, White Bldg 1st Flr) in Philadelphia, Pennsylvania.

Leah Turner's NPI, 1538663216, was assigned on March 19, 2018. Leah Turner holds Pennsylvania license SP018638.

Leah Turner's primary practice is Good Shepherd Penn Partners - HOPD (3400 Spruce Street, White Bldg 1st Flr), at 3400 Spruce Street, White Bldg 1st Flr, Philadelphia, PA 19104.

Leah Turner's primary practice is Good Shepherd Penn Partners - HOPD (3400 Spruce Street, White Bldg 1st Flr) in Philadelphia, Pennsylvania. Leah Turner is also affiliated with Hospital of the University of Pennsylvania. The medical group on file is Penn Medicine Lancaster General Health. Dmand AI also links Leah Turner to 3 more hospitals and 1 group practice or clinic, each named with a free account. Leah Turner's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Leah Turner practices, 6 sites in all. Vendor and product names are available with a free account.

Infectious disease is Leah Turner's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Leah Turner is licensed in Pennsylvania.

CMS data shows 133 Medicare services from Leah Turner across 3 procedure codes in 2024, for 81 Medicare patients. Medicare paid $9,185 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 81 Medicare patients who saw Leah Turner in 2024. The largest group is 65 to 74, with 44 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 20% are also on Medicaid. Their average risk score is 3.89, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Leah Turner's median patient age at 57, with 40% women.

In 2024, Leah Turner wrote 442 Medicare Part D claims for 144 patients. 66% of them were for generic drugs. CMS names the drug for 219 of them, across 8 drugs with 11 or more claims each, at $488,229 in total drug cost. In 2023, CMS named 142 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Leah Turner for performance year 2024, reported as part of a group. Leah Turner accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Leah Turner as offering telehealth.